Clinical Trial

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Study acronym: Melisa-II
Recruiting
View on ClinicalTrials.gov →
Summary
Study to evaluate the diagnostic precision of ICG and 99mTc nanocolloid albumin in sentinel lymph node detection in early ovarian epithelial cancer.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-07-06; most recent amendment 2026-02-05.
Status change: Not Yet Recruiting → Recruiting 2026-02-05
Trial Details
NCT Number NCT05937620
Lead Sponsor Fundacion Clinic per a la Recerca Biomédica
Conditions Ovarian Epithelial Cancer
Enrollment 62 participants
Start Date 2023-09-01
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2026-02-09